Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001763055 | SCV001989152 | uncertain significance | not provided | 2019-12-05 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002477931 | SCV002794025 | uncertain significance | Hypokalemic periodic paralysis, type 1; Potassium-aggravated myotonia; Paramyotonia congenita of Von Eulenburg; Hypokalemic periodic paralysis, type 2; Hyperkalemic periodic paralysis; Congenital myasthenic syndrome 16 | 2022-05-11 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001763055 | SCV003821277 | uncertain significance | not provided | 2021-03-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003365444 | SCV004054565 | uncertain significance | Inborn genetic diseases | 2023-08-20 | criteria provided, single submitter | clinical testing | The c.91C>T (p.R31W) alteration is located in exon 1 (coding exon 1) of the SCN4A gene. This alteration results from a C to T substitution at nucleotide position 91, causing the arginine (R) at amino acid position 31 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003505181 | SCV004272316 | uncertain significance | Hyperkalemic periodic paralysis | 2024-04-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 31 of the SCN4A protein (p.Arg31Trp). This variant is present in population databases (rs756059775, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with SCN4A-related conditions. ClinVar contains an entry for this variant (Variation ID: 1303597). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN4A protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |